Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,145.7
-21.3 (-0.67%)

 

  • STI Straits Times Index
    3,145.7
    -21.3 (-0.67%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,489.8
    -4.8 (-0.32%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,240.9
    279.9 (1.08%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,452.5
    55.1 (1.62%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,816.2
    532.6 (1.95%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,077.1
    7.1 (0.12%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 648.2M
  • Value: 624.0M
  • Rise: 146
  • Fall: 134
  • Unch: 481

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.115-
Rex Intl0.230+0.020
Genting Sing0.800-0.010
Abundance Intl0.046+0.004
KTL Global^0.122+0.004
YZJ Shipbldg SGD1.390+0.020
Raffles Edu0.090-0.010
Mercurius0.060-0.001
CapAllianz0.004-
ThaiBev0.635-0.015

World Indices

World Indices
Name Last Change
Nasdaq 14,672.7 -105.6
HSI 26,193.8 +232.8
HSCEI 9,327.6 +94.3
Jakarta 6,077.1 +7.1
Nikkei 225 27,791.7 +508.1
SSE Comp 3,455.1 +57.7
Shanghai A 3,621.3 +60.5
Shanghai B 256.6 +2.5
KOSPI 3,220.7 +18.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

INDIA GLOBALIZATION CAPITAL INC INDIA GLOBALIZATION CAPITAL
Updated on 30 Jul 2021 (End of trading day)
Last (USD): 1.770 Change: -0.030 High: 1.820 Remarks: -
Change (%): -1.67 Low: 1.730
Open 1.730 Yesterday's Close 1.8
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,472,735 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.28820 Trailing EPS (USD) e -0.28820 NAV (USD) b 1.0730
PE a - Trailing PE f - Price / NAV b 1.6496
Dividend (USD) d - Cash In Hand (USD) g 0.4759 Issued & Paid-up Shares c 48,327,300
Dividend Yield (%) d - Price / Cash In Hand g 3.719 Treasury Shares h -
Market Cap (M) 54.112 Enterprise Value (M) 40.549
Piotroski F Score 1 Exchange Code IGC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 145.67 Free Float (%) 86.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 14 Jun 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference INDIA GLOBALIZATION CAPITAL INC NYSE American 54.112 - - 1.6496 -
Industry Biotechnology NYSE American 150.302 - - 2.8134 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 532.940 - - 7.5339 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 426.431 - - 3.6236 -
Local Peer 22ND CENTURY GROUP INC NYSE American 329.860 - - 6.2843 -
Local Peer NANOVIRICIDES INC NYSE American 253.549 - - 7.9509 -
Local Peer BIOMX INC NYSE American 128.302 - - 2.3780 -
Local Peer IBIO INC NYSE American 115.096 - - 1.0977 -
Local Peer AIM IMMUNOTECH INC NYSE American 99.971 - - 1.4232 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 95.522 - - 2.8085 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 77.929 - - 1.2394 -
Local Peer CEL-SCI CORP NYSE American 74.968 - - 2.5559 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 66.971 - - 0.8413 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 64.960 - - 1.0331 -
Other Local Peers ORAGENICS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer MODERNA INC NASDAQ 141,980.301 - 237.359 36.9933 -
Global Peer AMGEN INC NASDAQ 138,777.773 19.105 19.588 14.8680 2.667
Global Peer AMGEN-T HKEx 1,011,789.594 17.959 18.421 13.9429 2.837
Global Peer CSL LTD ASX 131,491.319 41.925 34.550 12.4431 1.015
Global Peer GILEAD SCIENCES INC NASDAQ 85,647.952 696.339 23.530 - 3.982
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 79,303.420 4,577.583 54.561 26.7800 -
Global Peer ILLUMINA INC NASDAQ 72,379.500 110.335 114.888 14.7053 -
Global Peer WUXI BIO HKEx 486,094.206 256.138 256.137 19.9364 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,221.231 17.426 15.291 5.1116 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 52,182.208 19.244 27.111 - -
Other Global Peers BIOGEN INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SEAGEN INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB-SB (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), RECURSION PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EXELIXIS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARVINAS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), JOINN (HKEx), VIR BIOTECHNOLOGY INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), Lonza (SGX), KODIAK SCIENCES INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), KINTOR PHARMA-B (HKEx), LYELL IMMUNOPHARMA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), 23ANDME HOLDING CO (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), VERACYTE INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), INSMED INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALPHAMAB-B (HKEx), AMICUS THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), PROTHENA CORP PLC (NASDAQ), 3SBIO (HKEx), MORPHIC HOLDING INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), SEER INC (NASDAQ), INSTIL BIO INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), VIVA BIOTECH (HKEx), LIGAND PHARMACEUTICAL INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), NUVATION BIO INC (NYSE), C4 THERAPEUTICS INC (NASDAQ), JACOBIO-B (HKEx), HAOHAI BIOTEC (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), FRONTAGE (HKEx), NGM BIOPHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ASCENTAGE-B (HKEx), REPLIMUNE GROUP INC (NASDAQ), MACROGENICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), MAXCYTE INC (NASDAQ), VALNEVA SE SPON ADS EACH REPR 2 ORD SHS (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), BIOATLA INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), UNIQURE N.V. (NASDAQ), OCUGEN INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), JANUX THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ALLOVIR INC (NASDAQ), GRAPHITE BIO INC (NASDAQ), FIBROGEN INC (NASDAQ), TELIX PHARMACEUTIC (ASX), AGENUS INC (NASDAQ), PRECIGEN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), VAXCYTE INC (NASDAQ), POLYNOVO LIMITED (ASX), IMUGENE LIMITED (ASX), MONTE ROSA THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), JW THERAP-B (HKEx), STOKE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), IMMUNOVANT INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NAUTILUS BIOTECHNOLOGY INC (NASDAQ), HUMANIGEN INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PERSONALIS INC (NASDAQ), CARIBOU BIOSCIENCES INC (NASDAQ), MESOBLAST LTD (ASX), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), OMEROS CORP (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), IVERIC BIO INC (NASDAQ), VAXART INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), JHBP-B (HKEx), ITEOS THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), IMMATICS N V (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AMBRX BIOPHARMA INC SPON ADS EACH REP 7 ORD SHS (NYSE), AVIDITY BIOSCIENCES INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), MOLECULAR PARTNERS AG SPON ADS EACH REP 1 ORD SHS (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KADMON HLDGS INC (NASDAQ), SESEN BIO INC (NASDAQ), AKOYA BIOSCIENCES INC (NASDAQ), PASSAGE BIO INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), IMAGO BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CHIMERIX INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), COMPUGEN (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ESSEX BIO-TECH (HKEx), ZIOPHARM ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), DPHARMA (Bursa), VIKING THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RAIN THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), FORTE BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), VERA THERAPEUTICS INC. (NASDAQ), AKOUOS INC (NASDAQ), ATHERSYS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), PROQR THERAPEUTICS N V (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), ONCORUS INC (NASDAQ), OPTHEA LIMITED (ASX), CUE BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AVROBIO INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LEE'S PHARM (HKEx), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AEROVATE THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), IMMUTEP LTD (ASX), CYMABAY THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), KAMADA LTD (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), ADICET BIO INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), RANI THERAPEUTICS HLDGS INC (NASDAQ), ATRECA INC (NASDAQ), MIROMATRIX MEDICAL INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), NEXTCURE INC (NASDAQ), IMMUNOME INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), IN8BIO INC (NASDAQ), ELEVATION ONCOLOGY INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), HCW BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), GEMINI THERAPEUTIC (NASDAQ), MARKER THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SYNLOGIC INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), EQUILLIUM INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CYTOCOM INC (NASDAQ), SAVARA INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), LAVA THERAPEUTICS NV (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ENSYSCE BIOSCIENCES INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), AXCELLA HEALTH INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), IMV INC (NASDAQ), ORGENESIS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), BON NAT LIFE LTD (NASDAQ), BIONOMICS LTD (ASX), LEAF RESOURCES LTD (ASX), LONGEVERON INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), UNI-BIO GROUP (HKEx), AETERNA ZENTARIS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), ARAVIVE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CHIMERIC THERAPEUTICS LTD (ASX), MINERVA NEUROSCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ATYR PHARMA INC (NASDAQ), METACRINE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), COHBAR INC (NASDAQ), PATRYS LIMITED (ASX), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ALIMERA SCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), NABRIVA THERAPEUTICS PLC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), MICROBOT MEDICAL INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ENDURANCE RP (HKEx), CT ENTERPRISE (HKEx), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), TERRAGEN HOLDINGS LIMITED (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), ALTAMIRA THERAPEUTICS LTD (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), RHINOMED LIMITED (ASX), SOLIGENIX INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), HISTOGEN INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), MEMPHASYS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), TRANSCODE THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), Suntar Eco-City (SGX), ZIVO BIOSCIENCE INC (NASDAQ), ADITX INC (NASDAQ), BIOTRON (ASX), GEOVAX LABS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BIOSINO BIO-TEC (HKEx), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), PALISADE BIO INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REGENEUS LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ADALTA LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), ARGENICA THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX), HAO WEN HLDGS (HKEx), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.040
-2.21 %
10 Days -+0.380
+27.34 %
20 Days -+0.190
+12.03 %
Medium Term Return 3 Months -+0.200
+12.74 %
6 Months -+0.090
+5.36 %
1 Year -+1.040
+142.47 %
Long Term Return 2 Years -+0.640
+56.64 %
3 Years -+1.336
+307.83 %
5 Years -+1.240
+233.96 %
Annualised Return Annualised --
+27.27 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.583 - 4.650 Change From 1 Year Low +1.188 % Change From 1 Year Low (%) +203.86
Change From 1 Year High -2.880 % Change From 1 Year High (%) -61.94
2 Years Range 0.263 - 4.650 Change From 2 Years Low +1.507 % Change From 2 Years Low (%) +573.00
Change From 2 Years High -2.880 % Change From 2 Years High (%) -61.94
5 Years Range 0.190 - 14.580 Change From 5 Years Low +1.580 % Change From 5 Years Low (%) +831.58
Change From 5 Years High -12.810 % Change From 5 Years High (%) -87.86
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain. The firm is involved in researching the application of cannabinoids, such as Tetrahydrocannabinol and Cannabidiol in combination with other compounds to address various ailments, including Alzheimer's disease. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
30 Jul 2021 1.730 1.820 1.730 1.770 1,472,735 -
29 Jul 2021 1.970 1.978 1.775 1.800 3,376,060 -
28 Jul 2021 1.740 2.070 1.740 1.870 11,034,120 -
27 Jul 2021 1.790 1.790 1.665 1.770 3,626,858 -
26 Jul 2021 1.900 2.180 1.810 1.810 7,545,346 -
23 Jul 2021 2.360 2.380 1.860 1.880 23,198,730 -
22 Jul 2021 3.930 4.650 2.550 2.800 304,132,500 -
21 Jul 2021 1.430 1.500 1.420 1.480 549,521 -
20 Jul 2021 1.390 1.450 1.380 1.420 373,209 -
19 Jul 2021 1.400 1.440 1.360 1.390 557,029 -
16 Jul 2021 1.400 1.470 1.400 1.410 402,600 -
15 Jul 2021 1.400 1.460 1.400 1.410 464,226 -
14 Jul 2021 1.460 1.490 1.410 1.430 781,535 -
13 Jul 2021 1.470 1.500 1.450 1.480 698,225 -
12 Jul 2021 1.500 1.540 1.480 1.510 682,539 -
09 Jul 2021 1.500 1.570 1.470 1.520 1,166,001 -
08 Jul 2021 1.500 1.530 1.450 1.520 737,215 -
07 Jul 2021 1.600 1.600 1.520 1.520 1,005,857 -
06 Jul 2021 1.600 1.640 1.550 1.600 1,282,479 -
02 Jul 2021 1.690 1.690 1.550 1.580 2,672,585 -
01 Jul 2021 1.640 2.070 1.593 1.720 28,478,520 -
30 Jun 2021 1.580 1.670 1.570 1.640 1,068,150 -
Summary
Current 2 Weeks
(19 Jul 2021 to 30 Jul 2021)
1.400 4.650 1.360 1.770 355,866,108 -
Previous 2 Weeks
(02 Jul 2021 to 16 Jul 2021)
1.690 4.650 1.360 1.410 9,893,262 -
4 Weeks from
(04 Jun 2021 to 01 Jul 2021)
1.400 4.650 1.360 1.720 101,267,175 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.